Clinical trial
Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
NCT00293098 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Expanded access
- Overall status
- Approved for marketing
- Start date
- March 31, 2006
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.